A lumpectomy is intended to remove the breast cancer with an adequate rim of normal tissue while preserving the breast. When the laboratory report on the removed tissue shows a close or positive edge, called a margin, the next question is whether more surgery is actually necessary.
A “close” margin is not the same thing as a positive margin.
Margin decisions depend on whether the diagnosis is invasive cancer or ductal carcinoma in situ (DCIS), a noninvasive cancer contained within the milk ducts, the exact tissue-test results, planned radiation, the location and extent of disease near the margin, and the plan agreed upon by the care team.
What does “margin” mean after lumpectomy?
A laboratory doctor who examines tissue marks the outside of the removed tissue with ink and checks how close cancer cells come to that edge. A positive margin generally means tumor reaches the inked surface. A negative margin means it does not.
Invasive breast cancer: wider is not automatically better.
For invasive breast cancer treated with breast-conserving surgery and appropriate radiation, current breast-surgery guidance generally does not recommend another operation as a routine step when there is no tumor on ink. A close negative margin can still warrant individualized discussion when there are unusual laboratory findings or treatment considerations, but simply removing more normal breast tissue does not automatically improve cancer control.
DCIS uses a different margin framework.
For DCIS without invasive cancer treated with breast-conserving surgery and whole-breast radiation, a 2 mm negative margin remains a common benchmark. Margins narrower than 2 mm are handled more selectively and should be discussed in the context of the amount of disease near the edge, planned radiation, cosmetic impact of another operation, and the rest of the treatment plan.
When is another operation more likely?
Another operation is generally considered when cancer is present at the inked edge or when cancer is strongly suspected to remain, or when the margin does not meet the accepted standard for the specific diagnosis and treatment plan. In some situations, additional imaging, a second review of the tissue, or discussion among the care team helps clarify the decision.
The goal is cancer control without unnecessary surgery.
A second operation can affect recovery, breast shape, anxiety, and the timing of additional treatment. At the same time, leaving a truly inadequate margin can make it harder to prevent cancer from returning in the same breast. The decision should therefore be based on current margin standards and the individual case rather than a fixed desire for the widest possible margin.
Facing a breast-surgery decision?
Dr. Zadeh evaluates benign and cancer-related breast conditions in Sherman Oaks and can review the surgical options in the context of imaging and tissue-test results.